Exclusive License Agreement for Duke start-up, restor3D®
Ken Gall’s 3D-printing company, restor3D, has signed an exclusive license with SeaSpine, a global medical tech company.
SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into an exclusive (field-based) development and licensing agreement with restor3d, Inc., a privately-held medical device company co-founded by Ken Gall, Professor of Mechanical Engineering at Duke University, that specializes in developing 3D-printed implants with enhanced anatomical fit and superior integrative properties. Financial terms were not disclosed.
This partnership provides SeaSpine entry into, and an opportunity to differentiate within, the 3D-printed interbody space, one of the fastest growing segments in spine. restor3d’s materials science technology complements SeaSpine’s broad and differentiated orthobiologics portfolio with the goal of driving both clinical and economic advantages. The parties plan to develop 3D-printed interbody devices that are designed specifically for a wide range of surgical approaches. SeaSpine expects to commercialize its first 3D-printed interbody devices to be developed under this agreement in the second half of 2020.
“restor3d’s well-researched architecture provides a foundation for novel 3D interbody designs that thoughtfully balance structural integrity with the biological requirements for bony integration and fusion,” said Shaeffer Bannigan, Senior Director of Product Development at SeaSpine. “This foundation allows us to tune implant properties to optimal performance, merging biomechanical requirements with biologically favorable materials and structures.”
[Originally posted by Yahoo Finance — September 24, 2019]